G Cazzaniga
G Cazzaniga
monza
Email verificata su hsgerardo.org
TitoloCitata daAnno
Standardization and quality control studies of ‘real-time’quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection …
J Gabert, E Beillard, VHJ Van der Velden, W Bi, D Grimwade, ...
Leukemia 17 (12), 2318, 2003
14452003
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
JJM van Dongen, T Seriu, ER Panzer-Grümayer, A Biondi, ...
The Lancet 352 (9142), 1731-1738, 1998
10351998
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects
VHJ Van der Velden, A Hochhaus, G Cazzaniga, T Szczepanski, J Gabert, ...
Leukemia 17 (6), 1013, 2003
6492003
Prenatal origin of acute lymphoblastic leukaemia in children
JL Wiemels, G Cazzaniga, M Daniotti, OB Eden, GM Addison, G Masera, ...
The Lancet 354 (9189), 1499-1503, 1999
6361999
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the …
V Conter, CR Bartram, MG Valsecchi, A Schrauder, R Panzer-Grümayer, ...
Blood 115 (16), 3206-3214, 2010
5442010
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data
VHJ Van der Velden, G Cazzaniga, A Schrauder, J Hancock, P Bader, ...
Leukemia 21 (4), 604, 2007
5032007
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international …
T Flohr, A Schrauder, G Cazzaniga, R Panzer-Grümayer, ...
Leukemia 22 (4), 771, 2008
4052008
The MLL recombinome of acute leukemias in 2013
C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ...
Leukemia 27 (11), 2165, 2013
3372013
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
A Borkhardt, G Cazzaniga, S Viehmann, MG Valsecchi, WD Ludwig, ...
Blood 90 (2), 571-577, 1997
3321997
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
E Flex, V Petrangeli, L Stella, S Chiaretti, T Hornakova, L Knoops, ...
Journal of Experimental Medicine 205 (4), 751-758, 2008
3282008
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ...
The Lancet 372 (9648), 1484-1492, 2008
3092008
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
M Schrappe, MG Valsecchi, CR Bartram, A Schrauder, ...
Blood 118 (8), 2077-2084, 2011
2782011
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the …
L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ...
Blood 115 (5), 1006-1017, 2010
2682010
Genetic evidence for lineage-related and differentiation stage–related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia
M Tartaglia, S Martinelli, G Cazzaniga, V Cordeddu, I Iavarone, M Spinelli, ...
Blood 104 (2), 307-313, 2004
2622004
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
C Shochat, N Tal, OR Bandapalli, C Palmi, I Ganmore, G te Kronnie, ...
Journal of Experimental Medicine 208 (5), 901-908, 2011
2602011
Both carboxy-terminus NES motif and mutated tryptophan (s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML
B Falini, N Bolli, J Shan, MP Martelli, A Liso, A Pucciarini, B Bigerna, ...
Blood 107 (11), 4514-4523, 2006
2592006
Molecular analysis of the progression from Helicobacter pylori–associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach
E Zucca, F Bertoni, E Roggero, G Bosshard, G Cazzaniga, E Pedrinis, ...
New England Journal of Medicine 338 (12), 804-810, 1998
2541998
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
P Gorello, G Cazzaniga, F Alberti, MG Dell'Oro, E Gottardi, G Specchia, ...
Leukemia 20 (6), 1103, 2006
2482006
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
C Eckert, A Biondi, K Seeger, G Cazzaniga, R Hartmann, B Beyermann, ...
The Lancet 358 (9289), 1239-1241, 2001
2462001
Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis
D Bellavia, AF Campese, S Checquolo, A Balestri, A Biondi, G Cazzaniga, ...
Proceedings of the National Academy of Sciences 99 (6), 3788-3793, 2002
2182002
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20